Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Edward Bass currently holds 45,479 shares of REATA PHARMACEUTICALS INC (RETA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Edward Bass has been a net buyer of RETA stock. They have purchased $932.0K and sold $586.9K worth of shares.
James Edward Bass's most recent insider trade was on Nov 20, 2019, when they sold 6,000 shares at $0.00 per share.
James Edward Bass serves as Executive at REATA PHARMACEUTICALS INC (RETA). They have executed 19 insider transactions totaling $1.5M over their tenure at the company.
James Edward Bass holds the position of Executive at REATA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
James Edward Bass has shown a buying trading pattern, with $932.0K in total purchases and $586.9K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James Edward Bass was on Mar 5, 2019, when they sold $586.9K worth of RETA shares. This transaction involved 5,852 shares at $100.29 per share.
James Edward Bass currently owns 45,479 shares of REATA PHARMACEUTICALS INC (RETA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Edward Bass's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Edward Bass has 19 Form 4 filings on record as an insider at REATA PHARMACEUTICALS INC.
Set alerts for James Edward Bass and 40,000+ other insiders.